Locally advanced cervical cancer: Preliminary results of the prospective randomized study [PDF]
Archive of Oncology, 2003 Background: The aim of this study is to show preliminary results of the randomized study that has been conducted among patients with advanced cervical cancer managed by loco-regional radiotherapy alone or combined treatment (radiotherapy with ...
Stanković Vesna V. +5 more
doaj +1 more source
Efficacy and Prognostic Effect of Daratumumab-based Chemotherapy Regimen in Multiple Myeloma: a Real-world Study [PDF]
Zhongguo quanke yixue, 2023 Background Multiple myeloma (MM) is a common hematologic malignancy. With the emergence of a variety of new drugs, the survival rates of patients have increased, however, further discussion on how to achieve deeper and faster remission and reduce ...
WANG Jun, WU Jiafei, WANG Yijing, ZHENG Boyue, WANG Yu, JIANG Chuanyan, LI Hui
doaj +1 more source
The role of radiotherapy in combined treatment for locally advanced breast cancer with ipsilateral supraclavicular metastases [PDF]
Archive of Oncology, 2003 Background: Locally advanced breast cancer (LABC) includes a heterogeneous group of breast neoplasms classified from stage IIB, IIIA to IIIB. LABC with ipsilateral supraclavicular adenopathy without evidence of distant disease is included in the stage IV
Mladenović Jasmina +6 more
doaj +1 more source
Scalp cooling to prevent chemotherapy-induced alopecia, [PDF]
Anais Brasileiros de Dermatologia, 2020 Chemotherapy-induced alopecia causes an important impact on cancer patients and its risk of persistence is currently a considerable issue in cancer survivors.
Giselle de Barros Silva +3 more
doaj +1 more source
Efficacy and safety of bevacizumab in combination with irinotecan and capecitabine in first-line treatment of metastatic colorectal carcer [PDF]
Vojnosanitetski Pregled, 2017 Background/Aim. The efficacy and safety of bevacizumab (BEV) in combination with capecitabin and irinotecan in first-line therapy for patients with metastatic colorectal cancer (mCRC) were studied. In order to improve safety and efficacy of chemotherapy,
Jungić Saša +4 more
doaj +1 more source
Health care during administration of combined docetaxel-Mitomycin C-Vinblastin therapy in treatment of metastatic breast cancer patients [PDF]
Archive of Oncology, 2003 Background: New chemotherapy combinations are extensively investigated in metastatic breast cancer, especially in anthracycline resistant patients. However, the higher the treatment efficacy, usually the greater therapy side effects are reported.
Mitrović Jasmina +2 more
doaj +1 more source
BLEOMYCIN-INDUCED FLAGELLATE DERMATITIS: A CASE REPORT
Cogitare Enfermagem, 2015 Flagellate Dermatitis consists of cutaneous hyperpigmentation with a flagellate appearance, one specific cause of which is bleomycin. Bleomycin is a chemotherapy agent used in the treatment of different neoplasias.
Walfrido Bispo Junior +3 more
doaj +1 more source
Clinical Hematology International, 2020 Dose-adjusted rituximab, etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA.R-EPOCH) is used for upfront treatment of high-risk diffuse large B cell lymphoma (DLBCL).
Bhagirathbhai Dholaria +7 more
doaj +1 more source
Multifocal primary cutaneous extranodal NK/T lymphoma nasal type [PDF]
Anais Brasileiros de Dermatologia, 2016 Nasal type extranodal NK/T-cell lymphoma is a distinct entity according to the World Health Organization classification. Although 60% to 90% of patients with this disease present with a destructive mass in the midline facial tissues, it may also ...
Pedro de Vasconcelos +3 more
doaj +1 more source
Adverse drug reaction: a comparative analysis of protocols used for treatment of colorectal cancer
Medicina, 2017 Study design: Cohort study Objective: Analyze the adverse reactions that occurred in Brazilian patients with colorectal cancer submitted to chemotherapy with two different protocols, in order to identify the types and severity of those most frequent ...
Marcela Maciel Melo +2 more
doaj +1 more source